OA11277A - 4-Aminopyrrole (3,2-d)pyrimidines as Neuropeptide Y receptor antagonists. - Google Patents
4-Aminopyrrole (3,2-d)pyrimidines as Neuropeptide Y receptor antagonists. Download PDFInfo
- Publication number
- OA11277A OA11277A OA1200000007A OA1200000007A OA11277A OA 11277 A OA11277 A OA 11277A OA 1200000007 A OA1200000007 A OA 1200000007A OA 1200000007 A OA1200000007 A OA 1200000007A OA 11277 A OA11277 A OA 11277A
- Authority
- OA
- OAPI
- Prior art keywords
- alkyl
- methyl
- phenyl
- imidazo
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5473497P | 1997-08-05 | 1997-08-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA11277A true OA11277A (en) | 2003-07-29 |
Family
ID=21993163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200000007A OA11277A (en) | 1997-08-05 | 2000-01-14 | 4-Aminopyrrole (3,2-d)pyrimidines as Neuropeptide Y receptor antagonists. |
Country Status (32)
Country | Link |
---|---|
US (1) | US6187778B1 (fr) |
EP (1) | EP1003744B1 (fr) |
JP (1) | JP3711238B2 (fr) |
KR (1) | KR20010022583A (fr) |
CN (1) | CN1264381A (fr) |
AP (1) | AP9801312A0 (fr) |
AT (1) | ATE296825T1 (fr) |
AU (1) | AU7927498A (fr) |
BG (1) | BG104107A (fr) |
BR (1) | BR9811844A (fr) |
CA (1) | CA2293621C (fr) |
CO (1) | CO4960634A1 (fr) |
DE (1) | DE69830409T2 (fr) |
EA (1) | EA200000098A1 (fr) |
ES (1) | ES2241146T3 (fr) |
GT (1) | GT199800114A (fr) |
HR (1) | HRP980434A2 (fr) |
HU (1) | HUP0002956A3 (fr) |
ID (1) | ID24300A (fr) |
IL (1) | IL133430A0 (fr) |
IS (1) | IS5294A (fr) |
MA (1) | MA24629A1 (fr) |
NO (1) | NO996178L (fr) |
OA (1) | OA11277A (fr) |
PA (1) | PA8456601A1 (fr) |
PE (1) | PE106199A1 (fr) |
PL (1) | PL338575A1 (fr) |
SA (1) | SA98190435A (fr) |
TN (1) | TNSN98148A1 (fr) |
TR (1) | TR200000333T2 (fr) |
WO (1) | WO1999007703A1 (fr) |
ZA (1) | ZA986968B (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
CA2379633C (fr) * | 1999-09-30 | 2006-06-20 | Neurogen Corporation | Pyrazolo[1,5,-a]-1,5-pyrimidines et pyrazolo[1,5-a]-1,3,5-triazines amino substituees |
CZ301750B6 (cs) * | 1999-12-24 | 2010-06-09 | Aventis Pharma Limited | Bicyklický pyrrolový derivát, jeho použití pri výrobe léciva, farmaceutická kompozice tento derivát obsahující a pro použití pri lécení |
GB0117396D0 (en) | 2001-07-17 | 2001-09-05 | Glaxo Group Ltd | Chemical compounds |
GB0308208D0 (en) | 2003-04-09 | 2003-05-14 | Glaxo Group Ltd | Chemical compounds |
EP1752457B1 (fr) | 2004-06-02 | 2014-03-19 | Takeda Pharmaceutical Company Limited | Composé heterocyclique fusionné |
BRPI0512261A (pt) | 2004-06-17 | 2008-02-26 | Wyeth Corp | antagonistas de receptor de hormÈnio liberador de gonadotropina |
RU2007101509A (ru) | 2004-06-17 | 2008-07-27 | Уайт (Us) | Способ получения антагонистов рецепторов гормона, высвобождающего гонадотропин |
JP2008508358A (ja) * | 2004-08-02 | 2008-03-21 | オーエスアイ・ファーマスーティカルズ・インコーポレーテッド | アリール−アミノ置換ピロロピリミジンマルチキナーゼ阻害化合物 |
MY179032A (en) | 2004-10-25 | 2020-10-26 | Cancer Research Tech Ltd | Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors |
CA2596013C (fr) * | 2005-01-28 | 2012-06-05 | Daewoong Pharmaceutical Co., Ltd. | Derives de benzoimidazole et composition pharmaceutique contenant ceux-ci |
KR20060087386A (ko) | 2005-01-28 | 2006-08-02 | 주식회사 대웅제약 | 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물 |
US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
WO2006108218A1 (fr) * | 2005-04-15 | 2006-10-19 | Regenertech Pty Limited | Utilisation de neuropeptides y (npy) et d'agoniste d'antagonistes de ceux-ci pour regenerer des tissus |
US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
CA2614544C (fr) * | 2005-07-13 | 2013-09-10 | Banyu Pharmaceutical Co., Ltd. | Derive du benzimidazole a substitution par un heterocycle |
UY29825A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones |
UY29823A1 (es) * | 2005-10-03 | 2007-05-31 | Astrazeneca Ab | Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones |
JP2009531274A (ja) * | 2005-12-07 | 2009-09-03 | オーエスアイ・ファーマスーティカルズ・インコーポレーテッド | キナーゼ阻害性ピロロピリジン化合物 |
WO2007072017A2 (fr) * | 2005-12-22 | 2007-06-28 | The Institute Of Cancer Research | Inhibiteurs d'enzymes |
WO2007093901A1 (fr) | 2006-02-17 | 2007-08-23 | Pfizer Limited | Dérivés de 3-déazapurine en tant que modulateurs de tlr7 |
EP3421471B1 (fr) | 2006-04-25 | 2021-05-26 | Astex Therapeutics Limited | Dérivés de purine et de déazapurine comme composés pharmaceutiques |
PL2054405T3 (pl) | 2006-07-11 | 2014-03-31 | Dae Woong Pharma | Nowe pochodne biarylobenzimidazolu i zawierająca je kompozycja farmaceutyczna |
KR101134239B1 (ko) | 2006-07-11 | 2012-04-10 | 주식회사 대웅제약 | 신규한 바이아릴 벤조이미다졸 유도체 및 이를 함유하는 약학 조성물 |
CL2007002617A1 (es) | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
WO2008121064A1 (fr) * | 2007-03-30 | 2008-10-09 | Astrazeneca Ab | Nouveaux composés d'imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryle 705 |
DE102007027800A1 (de) | 2007-06-16 | 2008-12-18 | Bayer Healthcare Ag | Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung |
CN101861321B (zh) | 2007-10-11 | 2013-02-06 | 阿斯利康(瑞典)有限公司 | 作为蛋白激酶b抑制剂的吡咯并[2,3-d]嘧啶衍生物 |
NZ586642A (en) | 2008-01-11 | 2012-04-27 | Natco Pharma Ltd | Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents |
BR112013025410A2 (pt) | 2011-04-01 | 2016-12-20 | Astrazeneca Ab | tratamento terapêutico |
MX367640B (es) | 2011-11-30 | 2019-08-29 | Astrazeneca Ab | Tratamiento combinado del cáncer. |
AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3274213A (en) | 1961-09-05 | 1966-09-20 | Upjohn Co | Alkoxy-substituted 2-phenyl-1-(tertiary-aminoalkoxy)phenyl-3, 4-dihydronaphthalenes |
DE2818676A1 (de) * | 1978-04-27 | 1979-11-08 | Troponwerke Gmbh & Co Kg | Substituierte 5,6-dimethylpyrrolo 2,3-d pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
GB9022644D0 (en) * | 1990-10-18 | 1990-11-28 | Ici Plc | Heterocyclic compounds |
US5877178A (en) * | 1991-04-08 | 1999-03-02 | Duquesne University Of The Holy Ghost | Pyrimidine derivatives and methods of making and using these derivatives |
US5235053A (en) * | 1992-06-22 | 1993-08-10 | Eli Lilly And Company | Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates |
US5284971A (en) | 1992-07-16 | 1994-02-08 | Syntex (U.S.A.) Inc. | 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents |
DK0580550T3 (da) | 1992-07-21 | 1998-02-02 | Ciba Geigy Ag | Oxamidsyrederivater som hypercholesterolæmiske midler |
EP0682027B1 (fr) * | 1994-05-03 | 1997-10-15 | Novartis AG | Dérivés de la pyrrolopyrimidine avec une activité anti-proliférative |
PT783505E (pt) * | 1994-09-29 | 2001-08-30 | Novartis Ag | Pirrolo¬2,3-d|pirimidinas e sua utilizacao |
US6562862B1 (en) | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
AU692977B2 (en) | 1994-11-07 | 1998-06-18 | Pfizer Inc. | Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands |
US5644057A (en) * | 1995-05-12 | 1997-07-01 | Neurogen Corporation | Deazapurine derivatives; a new class of CRF1 specific ligands |
EP0759441A3 (fr) | 1995-06-30 | 1999-06-30 | Eli Lilly And Company | Procédés de traitement des pathologies associées aux peptides neuropeptide Y |
CA2242579A1 (fr) | 1996-01-09 | 1997-07-17 | Eli Lilly And Company | Antagonistes benzimidazolyles du recepteur du neuropeptide y |
-
1998
- 1998-07-10 DE DE69830409T patent/DE69830409T2/de not_active Expired - Fee Related
- 1998-07-10 EA EA200000098A patent/EA200000098A1/ru unknown
- 1998-07-10 JP JP2000506207A patent/JP3711238B2/ja not_active Expired - Fee Related
- 1998-07-10 ID IDW20000021A patent/ID24300A/id unknown
- 1998-07-10 IL IL13343098A patent/IL133430A0/xx unknown
- 1998-07-10 AU AU79274/98A patent/AU7927498A/en not_active Abandoned
- 1998-07-10 PL PL98338575A patent/PL338575A1/xx unknown
- 1998-07-10 BR BR9811844-7A patent/BR9811844A/pt not_active Application Discontinuation
- 1998-07-10 TR TR2000/00333T patent/TR200000333T2/xx unknown
- 1998-07-10 HU HU0002956A patent/HUP0002956A3/hu unknown
- 1998-07-10 US US09/380,901 patent/US6187778B1/en not_active Expired - Fee Related
- 1998-07-10 CA CA002293621A patent/CA2293621C/fr not_active Expired - Fee Related
- 1998-07-10 EP EP98929573A patent/EP1003744B1/fr not_active Expired - Lifetime
- 1998-07-10 AT AT98929573T patent/ATE296825T1/de not_active IP Right Cessation
- 1998-07-10 CN CN98807398A patent/CN1264381A/zh active Pending
- 1998-07-10 ES ES98929573T patent/ES2241146T3/es not_active Expired - Lifetime
- 1998-07-10 KR KR1020007001174A patent/KR20010022583A/ko not_active Application Discontinuation
- 1998-07-10 WO PCT/IB1998/001053 patent/WO1999007703A1/fr not_active Application Discontinuation
- 1998-07-27 GT GT199800114A patent/GT199800114A/es unknown
- 1998-07-30 PE PE1998000678A patent/PE106199A1/es not_active Application Discontinuation
- 1998-07-30 AP APAP/P/1998/001312A patent/AP9801312A0/en unknown
- 1998-08-03 PA PA19988456601A patent/PA8456601A1/es unknown
- 1998-08-04 MA MA25203A patent/MA24629A1/fr unknown
- 1998-08-04 ZA ZA9806968A patent/ZA986968B/xx unknown
- 1998-08-04 TN TNTNSN98148A patent/TNSN98148A1/fr unknown
- 1998-08-04 HR HR60/054,734A patent/HRP980434A2/hr not_active Application Discontinuation
- 1998-08-05 CO CO98044925A patent/CO4960634A1/es unknown
- 1998-08-19 SA SA98190435A patent/SA98190435A/ar unknown
-
1999
- 1999-12-10 IS IS5294A patent/IS5294A/is unknown
- 1999-12-14 NO NO996178A patent/NO996178L/no not_active Application Discontinuation
-
2000
- 2000-01-14 OA OA1200000007A patent/OA11277A/en unknown
- 2000-01-26 BG BG104107A patent/BG104107A/bg unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA11277A (en) | 4-Aminopyrrole (3,2-d)pyrimidines as Neuropeptide Y receptor antagonists. | |
US6337332B1 (en) | Neuropeptide Y receptor antagonists | |
EP0923581B1 (fr) | Beta-carbolines substituees en position 4 utilisees comme immunomodulateurs | |
US20070275990A1 (en) | Heterocyclic Spiro Compound | |
US20080249154A1 (en) | Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates | |
JP2007521328A (ja) | アンドロゲン受容体モジュレーター | |
DE19756036A1 (de) | Amid- und Harnstoffderivate | |
US8748422B2 (en) | Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist | |
US20190175554A1 (en) | Method for treating pruritus and/or itch | |
US6407120B1 (en) | Neuropeptide Y antagonists | |
AU726676B2 (en) | 4-aminopyrrole (3,2-d) pyrimidines as Neuropeptide Y Receptor Antagonists | |
CA2299013C (fr) | Antagonistes du neuropeptide y | |
Cannon et al. | 6-Hydroxy-4-[2-di-n-propylaminoethyl] indole: synthesis and dopaminergic actions | |
EP1027891B1 (fr) | Antagonistes du neuropeptide Y | |
US20080312253A1 (en) | Pharmaceutical compositions containing pyrazole derivatives for treating as serotonin antagonist | |
CZ439199A3 (cs) | 4-Aminopyrrol(3^-d)pyrimidiny jako antagonisty receptoru neuropeptidu Y | |
MXPA99012095A (es) | 4-aminopirrol (3,2-d) pirimidinas como antagonistas del receptor del neuropeptido y | |
AU2011376747A1 (en) | Indanyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them | |
MXPA00001707A (en) | Amide derivatives useful as neuropeptide y (npy) antagonists | |
CZ296877B6 (cs) | Chinolinový derivát, jeho pouzití pro výrobu léciva pro lécení bolesti a farmaceutický prostredek sjeho obsahem | |
JP2006501244A5 (fr) | ||
JPS62185086A (ja) | 2−アミノ−3−ホルミルフラン |